Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:antineoplastic_agent |
| gptkbp:administered_via |
oral route
|
| gptkbp:ATCCode |
J04AK02
|
| gptkbp:CASNumber |
1070-11-7
|
| gptkbp:contraindication |
optic neuritis
children under 13 years |
| gptkbp:developedBy |
gptkb:Lederle_Laboratories
|
| gptkbp:discoveredBy |
1961
|
| gptkbp:hasMolecularFormula |
C10H24N2O2·2HCl
|
| gptkbp:is_salt_of |
gptkb:ethambutol
|
| gptkbp:meltingPoint |
200-205°C
|
| gptkbp:molecularWeight |
277.24 g/mol
|
| gptkbp:sideEffect |
optic neuritis
visual disturbances |
| gptkbp:usedFor |
treatment of tuberculosis
|
| gptkbp:bfsParent |
gptkb:ethambutol
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
ethambutol hydrochloride
|